• Mashup Score: 7

    Children with Down syndrome (DS, trisomy 21) are at a significantly higher risk of developing acute leukemia compared to the overall population. Many studies investigating the link between trisomy 21 (T21) and leukemia initiation and progression have been conducted over the last two decades. Despite improved treatment regimens and significant progress in identifying genes on chromosome 21 and the mechanisms by which they drive leukemogenesis, there is still much that is unknown. A focused group of scientists and clinicians with expertise in leukemia and Down syndrome met in October 2022 at the Jérôme Lejeune Foundation in Paris, France for the 1st International Symposium on Down Syndrome and Leukemia. This meeting was held to discuss the most recent advances in treatment regimens and the biology underlying the initiation, progression, and relapse of acute lymphoblastic leukemia and acute myeloid leukemia in children with DS. This review provides a summary of what is known in the field,

    Tweet Tweets with this article
    • Read here a new review on the management of #DownSyndrome patients with #leukemia: what is known, key questions in the field, and challenges. https://t.co/RkSc2LwDRC https://t.co/ogK9gKXWCD

  • Mashup Score: 8

    Objective To evaluate the frequency of medical imaging or estimated associated radiation exposure in children with Down syndrome. Methods This retrospective cohort study included 4,348,226 children enrolled in six U.S. integrated healthcare systems from 1996–2016, 3,095 of whom were diagnosed with Down syndrome. We calculated imaging rates per 100 person years and associated red bone marrow dose (mGy). Relative rates (RR) of imaging in children with versus without Down syndrome were estimated using overdispersed Poisson regression. Results Compared to other children, children with Down syndrome received imaging using ionizing radiation at 9.5 times (95% confidence interval[CI] = 8.2–10.9) the rate when age <1 year and 2.3 times (95% CI = 2.0–2.5) between ages 1–18 years. Imaging rates by modality in children <1 year with Down syndrome compared with other children were: computed tomography (6.6 vs. 2.0, RR = 3.1[95%CI = 1.8–5.1]), fluoroscopy (37.1 vs. 3.1, RR 11.9[95%CI 9.5–14.8]), ang

    Tweet Tweets with this article
    • New study spotlights radiation exposure from #medicalImaging for children with #DownSyndrome @PLOSONE https://t.co/v91CBpMidX https://t.co/goTeuhcvPr